Korea United Pharm Inc. (KRX:033270)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,700
-160 (-0.81%)
At close: Apr 16, 2025, 3:30 PM KST

Korea United Pharm Revenue

Korea United Pharm had revenue of 39.95B KRW in the quarter ending September 30, 2015, with 6.10% growth. This brings the company's revenue in the last twelve months to 161.44B, up 8.00% year-over-year. In the year 2014, Korea United Pharm had annual revenue of 155.19B with 13.37% growth.

Revenue (ttm)
161.44B
Revenue Growth
+8.00%
P/S Ratio
1.79
Revenue / Employee
242.76M
Employees
665
Market Cap
288.78B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2014155.19B18.30B13.37%
Dec 31, 2013136.89B2.06B1.53%
Dec 31, 2012134.83B-10.62B-7.30%
Dec 31, 2011145.45B10.47B7.76%
Dec 31, 2010134.98B15.89B13.35%
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Mar 31, 2007 Pro Pro Pro
Mar 31, 2006 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,547.32B
Celltrion 3,557.30B
ALTEOGEN 102.85B
Yuhan 2,067.79B
SK Biopharmaceuticals 547.60B
HLB Co., Ltd. 68.13B
Peptron 3.15B
LigaChem Biosciences 125.90B
Revenue Rankings